268 related articles for article (PubMed ID: 28549713)
1. Childhood opsoclonus-myoclonus syndrome: A case series from Tunisia.
Ben Achour N; Mrabet S; Rebai I; Abid I; Benrhouma H; Klaa H; Rouissi A; Kraoua I; Ben Youssef Turki I
Brain Dev; 2017 Oct; 39(9):751-755. PubMed ID: 28549713
[TBL] [Abstract][Full Text] [Related]
2. A nationwide survey of opsoclonus-myoclonus syndrome in Japanese children.
Hasegawa S; Matsushige T; Kajimoto M; Inoue H; Momonaka H; Oka M; Ohga S; Ichiyama T;
Brain Dev; 2015 Aug; 37(7):656-60. PubMed ID: 25454391
[TBL] [Abstract][Full Text] [Related]
3. Early Detection and Treatment of Neuroblastic Tumor with Opsoclonus-Myoclonus Syndrome Improve Neurological Outcome: A Review of Five Cases at a Single Institution in Japan.
Takama Y; Yoneda A; Nakamura T; Nakaoka T; Higashio A; Santo K; Kuki I; Kawawaki H; Tomiwa K; Hara J
Eur J Pediatr Surg; 2016 Feb; 26(1):54-9. PubMed ID: 26409265
[TBL] [Abstract][Full Text] [Related]
4. Childhood opsoclonus-myoclonus syndrome: diagnosis and treatment.
Blaes F; Dharmalingam B
Expert Rev Neurother; 2016 Jun; 16(6):641-8. PubMed ID: 27095464
[TBL] [Abstract][Full Text] [Related]
5. Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-up.
Catsman-Berrevoets CE; Aarsen FK; van Hemsbergen ML; van Noesel MM; Hakvoort-Cammel FG; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2009 Dec; 53(6):1048-53. PubMed ID: 19672966
[TBL] [Abstract][Full Text] [Related]
6. Multifactorial analysis of opsoclonus-myoclonus syndrome etiology ("Tumor" vs. "No tumor") in a cohort of 356 US children.
Pranzatelli MR; Tate ED; McGee NR
Pediatr Blood Cancer; 2018 Aug; 65(8):e27097. PubMed ID: 29727049
[TBL] [Abstract][Full Text] [Related]
7. Monocentric retrospective clinical outcome in a group of 13 patients with opsoclonus myoclonus syndrome, proposal of diagnostic algorithm and review of the literature.
Urtiaga Valle S; Souvannanorath S; Leboucq N; Haouy S; Rivier F; Roubertie A; Meyer P
Eur J Paediatr Neurol; 2022 Sep; 40():18-27. PubMed ID: 35926472
[TBL] [Abstract][Full Text] [Related]
8. Rituximab treatment for relapsed opsoclonus-myoclonus syndrome.
Toyoshima D; Morisada N; Takami Y; Kidokoro H; Nishiyama M; Nakagawa T; Ninchoji T; Nozu K; Takeshima Y; Takada S; Nishio H; Iijima K
Brain Dev; 2016 Mar; 38(3):346-9. PubMed ID: 26375512
[TBL] [Abstract][Full Text] [Related]
9. Increased Prevalence of Familial Autoimmune Disease in Children With Opsoclonus-Myoclonus Syndrome.
Santoro JD; Kerr LM; Codden R; Casper TC; Greenberg BM; Waubant E; Kong SW; Mandl KD; Gorman MP
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34475249
[TBL] [Abstract][Full Text] [Related]
10. Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS).
Krasenbrink I; Fühlhuber V; Juhasz-Boess I; Stolz E; Hahn A; Kaps M; Hero B; Blaes F
Neuropediatrics; 2007 Jun; 38(3):114-6. PubMed ID: 17985258
[TBL] [Abstract][Full Text] [Related]
11. Long-term neurological outcomes of children with neuroblastoma with opsoclonus-myoclonus syndrome.
Sun Q; Wang Y; Xie Y; Wu P; Li S; Zhao W
Transl Pediatr; 2022 Mar; 11(3):368-374. PubMed ID: 35378965
[TBL] [Abstract][Full Text] [Related]
12. [Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
Zhao W; Sun Q; Xie Y; Hua Y; Xiong H; Jia J; Lu X
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):540-3. PubMed ID: 25224062
[TBL] [Abstract][Full Text] [Related]
13. Clinical profile and outcome of children with opsoclonus-myoclonus syndrome.
Singhi P; Sahu JK; Sarkar J; Bansal D
J Child Neurol; 2014 Jan; 29(1):58-61. PubMed ID: 23318697
[TBL] [Abstract][Full Text] [Related]
14. High dose pulsatile dexamethasone therapy in children with opsoclonus-myoclonus syndrome.
Rostásy K; Wilken B; Baumann M; Müller-Deile K; Bieber I; Gärtner J; Möller P; Angelini P; Hero B
Neuropediatrics; 2006 Oct; 37(5):291-5. PubMed ID: 17236108
[TBL] [Abstract][Full Text] [Related]
15. An upfront immunomodulatory therapy protocol for pediatric opsoclonus-myoclonus syndrome.
Wilbur C; Yea C; Licht C; Irwin MS; Yeh EA
Pediatr Blood Cancer; 2019 Aug; 66(8):e27776. PubMed ID: 31033188
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.
Armangué T; Sabater L; Torres-Vega E; Martínez-Hernández E; Ariño H; Petit-Pedrol M; Planagumà J; Bataller L; Dalmau J; Graus F
JAMA Neurol; 2016 Apr; 73(4):417-24. PubMed ID: 26856612
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus.
Bataller L; Graus F; Saiz A; Vilchez JJ;
Brain; 2001 Feb; 124(Pt 2):437-43. PubMed ID: 11157570
[TBL] [Abstract][Full Text] [Related]
18. [Clinical diagnosis and therapy of opsoclonus-myoclonus syndrome].
Xiong H; Peng J; Zhang YH; Bao XH; Jiang YW; Qin J
Zhonghua Er Ke Za Zhi; 2008 Aug; 46(8):570-3. PubMed ID: 19099827
[TBL] [Abstract][Full Text] [Related]
19. Effect of Increased Immunosuppression on Developmental Outcome of Opsoclonus Myoclonus Syndrome (OMS).
Mitchell WG; Wooten AA; O'Neil SH; Rodriguez JG; Cruz RE; Wittern R
J Child Neurol; 2015 Jul; 30(8):976-82. PubMed ID: 25342308
[TBL] [Abstract][Full Text] [Related]
20. Acute transverse myelitis following an opsoclonus-myoclonus syndrome: An unusual presentation.
Simon T; Cheuret E; Fiedler L; Mengelle C; Baudou E; Deiva K
Eur J Paediatr Neurol; 2018 Sep; 22(5):878-881. PubMed ID: 29773357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
